About Urvogelbio
Urvogelbio was a Healthcare company based in Hyderabad (India) founded in 2017 by Sasidhar Manda. It develops innovative exosome-based biomarkers for advanced healthcare applications. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Biomarkers and Exosome Technology. Its legal entity in India is Urvogelbio Private Limited (U74999TG2017PTC121419).
Company details
Urvogelbio operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, biomarkers, and exosome technology. Develops innovative exosome-based biomarkers for advanced healthcare applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Hyderabad, India
- Founders Sasidhar Manda
- SectorsHealthcare
- Website urvogelbio.com
- Legal Name Urvogelbio Private Limited
- Date of Incorporation 26 Dec, 2017
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹21,800
FY 2025 · +73% YoY
- Net Loss-₹6.9 Lakh
FY 2025 · -3172% margin
- EBITDA-₹6.9 Lakh
FY 2025 · -3165% margin
Associated legal entities of Urvogelbio
Urvogelbio operates through Urvogelbio Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Urvogelbio Private Limited CIN U74999TG2017PTC121419 | Active | 26 Dec 2017 | Hyderabad, Telangana | ₹0.0 Cr | 2 | View details |
Board of directors of Urvogelbio Private Limited (Urvogelbio)
Urvogelbio Private Limited is the primary company behind Urvogelbio. The board of Urvogelbio Private Limited currently have 2 directors; the longest-serving is Venkata Sasidhar Manda, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkata Sasidhar Manda DIN 07644544 | Director | 26 Dec 2017 | 8 yrs 10 mo | Urvogelbio Private Limited |
| Subashini Prabhakar DIN 08020463 | Director | 26 Dec 2017 | 8 yrs 10 mo | Urvogelbio Private Limited |
People of Urvogelbio
1 people are tracked at Urvogelbio (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for Urvogelbio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Urvogelbio
Figures of Urvogelbio Private Limited, the primary company behind Urvogelbio, for FY 2025. Revenue was ₹21,800 (+73% year on year). Net loss was -₹6.9 Lakh (-3172% margin). EBITDA was -₹6.9 Lakh (-3165% margin).
- ₹21,800Revenue · FY 2025 · +73% YoY
- -₹6.9 LakhNet loss · -3172% margin
- -₹6.9 LakhEBITDA · -3165% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Urvogelbio Private Limited are on its company page.
Detailed financial statements for Urvogelbio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Urvogelbio
Urvogelbio was founded in 2017.
Urvogelbio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Urvogelbio, Urvogelbio Private Limited, reported revenue of ₹21,800 for FY 2025, up 73% year on year.
Urvogelbio operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, biomarkers, and exosome technology. Develops innovative exosome-based biomarkers for advanced healthcare applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Urvogelbio operates through Urvogelbio Private Limited.
The legal entities of Urvogelbio currently have 2 directors, including Venkata Sasidhar Manda, Subashini Prabhakar.